EP4153136
Osmósu-skammtaform sem innihalda deutetrabenasín og aðferðir til notkunar á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.6.2021EP published:
10.1.2024EP application number:
21737870.2
EP translation filed:
18.3.2024Grant published:
15.4.2024EPO information:
European Patent Register
Max expiry date:
9.6.2041Expiry date:
9.6.2026Next due date:
30.6.2026
Title in English:
OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOFLanguage of the patent:
English
Timeline
Today
10.6.2021EP application
10.1.2024EP Publication
18.3.2024Translation submitted
15.4.2024Registration published
9.6.2026Expires
Owner
Name:
Auspex Pharmaceuticals, Inc.Address:
400 Interpace Parkway, Parsippany, NJ 07054, US
Inventor
Name:
SHAH, ParagAddress:
North Wales, PA 19454, US
Name:
JOSHI, MayankAddress:
Weston, FL 33327, US
Name:
PATTANAYEK, SoumenAddress:
North Wales, PA 19454, US
Name:
PATEL, DivyangAddress:
North Wales, PA 19454, US
Name:
PANDITA, SandeepAddress:
Parsippany, NJ 07054, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
202063037369 PDate:
10.6.2020Country:
US
Number:
202063037953 PDate:
11.6.2020Country:
US
Number:
202063044451 PDate:
26.6.2020Country:
US
Classification
Categories:
A61K 31/4747, A61K 9/00, A61K 9/28, A61K 9/20, A61K 47/10, A61K 47/38, A61K 31/473, A61P 25/14, A61P 25/28, A61K 31/4745
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 21.5.2024
Expires: 9.6.2025
Payer: Árnason Faktor ehf.
Number: 5
Paid: 4.6.2025
Expires: 9.6.2026
Payer: Árnason Faktor ehf.